API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

Zinc Pyrithione: A Promising Anti-Fungal Compound for Dermatologic Applications

Zinc Pyrithione has high skin permeability and exhibits anti-fungal activity against Malassezia yeast, commonly used in medicated shampoos for treating dandruff and seborrheic dermatitis.

Jan 9,2024  API

Agar-based edible films for food packaging applications

Agar can create edible films with gelling ability. Adding components like plasticizers and biopolymers improves flexibility and functional properties, expanding applications.

Jan 9,2024  API

A first-in-class potent 5-HT2A antagonist: Lumateperone

Lumateperone, also known as ITI-007, is a first-in-class potent 5-HT2A antagonist, postsynaptic D2 antagonist, and inhibitor of serotonin transport developed by Intra-Cellular Therapies under a licens

Jan 8,2024  API

The synthesis method of Lemborexant

Lemborexant is an orally administered dual orexin receptor (OXR) antagonist developed by Eisai for the treatment of adults with insomnia.

Jan 8,2024  API

How Lasmiditan works in treating migraine

Lasmiditan, or COL-144, is an orally bioavailable selective serotonin receptor agonist (SSRA) discovered by Eli Lilly and Company and licensed to CoLucid Pharmaceuticals before Eli Lilly acquired CoLu

Jan 8,2024  API

How to synthesize Brexanolone?

Developed by Sage Therapeutics, brexanolone was approved by the USFDA as a first-in-class treatment for PPD in adult women.

Jan 8,2024  API

2-Methyl-3-(3,4-methylenedioxyphenyl)propanal induces Ca2+ decrease and serotonin secretion via a PKG-mediated pathway

2-Methyl-3-(3,4-methylenedioxyphenyl)propanal can induce a dose-dependent decrease in Ca2+ levels in QGP-1 cells, potentially important for fragrance development and olfactory research.

Jan 8,2024  API

Fenbendazole: An Antitumor Agent with Effects on Bone Marrow and Immune System

Fenbendazole shows potential antitumor effects in studies and further research finds its associated risks and complex effects on the bone marrow and immune system.

Jan 8,2024  API

Potassium Sorbate: Versatile and Effective Food Preservative with Alkylating Potential

Potassium sorbate is a commonly used food preservative with low toxicity and high solubility and exhibits alkylating potential, but further research is needed on its implications for human health.

Jan 5,2024  API

A relaxed-state (R-state) stabilizer of hemoglobin: Voxelotor

Voxelotor, also known as GBT440, is a relaxed-state (R-state) stabilizer of hemoglobin developed by Global Blood Therapeutics and approved by the USFDA for treating sickle cell disease.

Jan 5,2024  API
Prev12345678910...Next>  Go to Page